Showing results (111-120 of 175) with videos related to
Sort By:
Pageof 18
European Journal of Medicinal Chemistry|December 25, 2025
Fluorinated HIV-1 protease inhibitors containing chiral hydroxyethylbenzene and indanol as P2' ligands with potent activity against drug-resistant variantsJagroop Kaur, Ean Spielvogel, Desaboini Nageswara Rao, et al.AIDS Research and Human Retroviruses|January 10, 2020
HIV-1 Central Nervous System Compartmentalization and Cytokine Interplay in Non-Subtype B HIV-1 Infections in Nigeria and MalawiOlubusuyi Moses Adewumi, Elena Dukhovlinova, Nathan Y Shehu, et al.Elife|March 15, 2023
Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistanceEan Spielvogel, Sook-Kyung Lee, Shuntai Zhou, et al.Biorxiv : the Preprint Server for Biology|September 4, 2023
<i>N</i><sup>4</sup> -Hydroxycytidine/Molnupiravir Inhibits RNA-Virus Induced Encephalitis by Producing Mutated Viruses with Reduced FitnessDurbadal Ojha, Collin S Hill, Shuntai Zhou, et al.Antiviral Research|August 7, 2018
Evolutionary pathways to NS5A inhibitor resistance in genotype 1 hepatitis C virusShuntai Zhou, Sara E Williford, David R McGivern, et al.European Journal of Medicinal Chemistry|May 27, 2023
HIV-1 protease inhibitors with a P1 phosphonate modification maintain potency against drug-resistant variants by increased interactions with flap residuesGordon J Lockbaum, Linah N Rusere, Mina Henes, et al.AIDS (London, England)|May 6, 2009
Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease coursePatrick R Harrington, Gretja Schnell, Scott L Letendre, et al.Journal of Medicinal Chemistry|July 17, 2020
Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide IsostereLinah N Rusere, Gordon J Lockbaum, Mina Henes, et al.Plos Pathogens|September 30, 2024
N4-Hydroxycytidine/molnupiravir inhibits RNA virus-induced encephalitis by producing less fit mutated virusesDurbadal Ojha, Collin S Hill, Shuntai Zhou, et al.AIDS (London, England)|April 20, 2004
Clinical and immunological impact of HIV envelope V3 sequence variation after starting initial triple antiretroviral therapyZabrina L Brumme, Winnie W Y Dong, Benita Yip, et al.Pageof 18